INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study

INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study

Bibliographic Details
Main Authors:	Giordano, Frank A, Brehmer, Stefanie, Abo-Madyan, Yasser, Welzel, Grit, Sperk, Elena, Keller, Anke, Schneider, Frank, Clausen, Sven, Herskind, Carsten, Schmiedek, Peter, Wenz, Frederik
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364103/

Similar Items

TARGIT-E(lderly)—Prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer
by: Neumaier, Christian, et al.
Published: (2012)

Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity
by: Shelan, Mohamed, et al.
Published: (2013)

A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer
by: Sperk, Elena, et al.
Published: (2014)

Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A
by: Welzel, Grit, et al.
Published: (2013)

Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?
by: Aziz, Muhammad Hammad, et al.
Published: (2011)

Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques
by: Aly, Moamen M.O.M., et al.
Published: (2015)

Comparison of breast sequential and simultaneous integrated boost using the biologically effective dose volume histogram (BEDVH)
by: Aly, Moamen M. O. M., et al.
Published: (2016)

Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy
by: Nguyen, Dan, et al.
Published: (2014)

The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer
by: Mai, Sabine Kathrin, et al.
Published: (2007)

Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS)
by: Kraus-Tiefenbacher, Uta, et al.
Published: (2012)

Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy x-rays
by: Tuschy, Benjamin, et al.
Published: (2013)

TGF-β1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT)
by: Scherer, Sandra D., et al.
Published: (2016)

The Biological Effect of Large Single Doses: A Possible Role for Non-Targeted Effects in Cell Inactivation
by: Veldwijk, Marlon R., et al.
Published: (2014)

Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization
by: Maier, Patrick, et al.
Published: (2016)

Glioblastoma Multiforme
by: Sheehan, Jonas M., et al.
Published: (2012)

Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme
by: Kusumawidjaja, Grace, et al.
Published: (2016)

Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2–3 diarrhoea
by: Reis, Tina, et al.
Published: (2015)

Understanding cytoskeleton regulators in glioblastoma multiforme for therapy design
by: Masoumi, Samaneh, et al.
Published: (2016)

Tectal plate glioblastoma multiforme
by: Nemer, Michael D., et al.
Published: (2011)

Bilateral cystic glioblastoma multiforme
by: Kumar, Sushil, et al.
Published: (2013)

Visual Epilepsy in Glioblastoma Multiforme
by: ZAINAB BINTI AWANG NGAH
Published: (2008)

The complement system in glioblastoma multiforme
by: T. A. M. Bouwens van der Vlis, et al.
Published: (2018-09-01)

Glioblastoma multiforme – an overview
by: Urbańska, Kaja, et al.
Published: (2014)

Incidentalomas to glioblastoma multiforme
by: Sachdev, Bobby, et al.
Published: (2014)

Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme
by: Lim, Sun Min, et al.
Published: (2015)

Canadian recommendations for the treatment of glioblastoma multiforme
by: Mason, W.P., et al.
Published: (2007)

Supratentorial glioblastoma multiforme with spinal metastases
by: Shah, Abhidha, et al.
Published: (2010)

Glioblastoma Multiforme: Novel Therapeutic Approaches
by: Fialho, Arsenio M., et al.
Published: (2012)

Pediatric Cerebellar Hemorrhagic Glioblastoma Multiforme
by: Kalina, Peter
Published: (2012)

Morphometic analysis of TCGA glioblastoma multiforme
by: Chang, Hang, et al.
Published: (2011)

Network Signatures of Survival in Glioblastoma Multiforme
by: Patel, Vishal N., et al.
Published: (2013)

Glioblastoma Multiforme Therapy and Mechanisms of Resistance
by: Ramirez, Yulian P., et al.
Published: (2013)

NTRK1 Fusion in Glioblastoma Multiforme
by: Kim, Jinkuk, et al.
Published: (2014)

Network signatures of survival in glioblastoma multiforme.
by: Vishal N Patel, et al.

Immunomodulation - hope for patient with Glioblastoma Multiforme
by: Jakub Litak, et al.
Published: (2018-09-01)

Glioblastoma Multiforme Classified As Mesenchymal Subtype
by: Koev Ilian G., et al.
Published: (2014-09-01)

Cancer Stem Cells in Glioblastoma Multiforme
by: Bradshaw, Amy, et al.
Published: (2016)

Emerging treatment strategies for glioblastoma multiforme
by: Carlsson, Steven K, et al.
Published: (2014)

Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme
by: Schiefer, L., et al.
Published: (2014)

Pacemaker and radiotherapy in breast cancer: is targeted intraoperative radiotherapy the answer in this setting?
by: Keshtgar, Mohammed RS, et al.
Published: (2012)